secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRADIMED CORP (IRMD)
CIK:        0001325618
Form:       8-K
Filed at:   2025-09-02T23:59:59+00:00
Accession:  0001558370-25-011834
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iradimed appoints Masimo founder Joe Kiani to board; Anthony Vuoto retires
--------------------------------------------------------------------------

- Anthony Vuoto retired as director effective Aug 27, 2025; no disagreement with the company.
- Joe Kiani, founder of Masimo and CEO of Willow Laboratories, appointed director effective Sep 2, 2025.
- Kiani will serve on the Audit Committee and chair the Compensation Committee.
- Board size remains at five directors after the transition.
- Kiani receives standard non-employee director compensation as disclosed in the 2025 proxy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1325618/000155837025011834/0001558370-25-011834-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1325618/000155837025011834/irmd-20250827x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-011834

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer